Impact of α1-blockers in men with spinal cord injury and upper tract stasis

Journal of Spinal Cord Medicine

Volumn 25, Issue 2, 2002, Pages 124-128

  Linsenmeyer, Todd A ^a,b   Horton, John ^a,c   Benevento, Joseph ^a  

^a KESSLER INSTITUTE FOR REHABILITATION   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Neurogenic bladder; Prazosin; Spinal cord injuries; Terazosin; Urodynamics; 1 adrenergic blockers

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PRAZOSIN; TERAZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; TERAZOSINE;

ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BLADDER CONTRACTION; CLINICAL ARTICLE; DETRUSOR MUSCLE; DRUG EFFICACY; HUMAN; MALE; MICTURITION; NEUROGENIC BLADDER; SPINAL CORD INJURY; URODYNAMICS; CONVALESCENCE; DRUG ANTAGONISM; DRUG EFFECT; INJURY SCALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; URINARY TRACT; URINARY TRACT DISEASE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; HUMANS; MALE; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; TIME FACTORS; TRAUMA SEVERITY INDICES; TREATMENT OUTCOME; URINARY TRACT; URODYNAMICS; UROLOGIC DISEASES;

EID: 0036595811     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2002.11753612     Document Type: Article

References (21)

1. Lincoln J, Crowe R, Bokor J, Light JK, Chilton CP, Burnstock B. Adrenergic and cholinergic innervation of the smooth and striated muscle components of the urethra from patients with SCI. J Urol. 1986;135:402-446.
2. Wein AJ. Neuromuscular dysfunction of the lower urinary tract. In: Walsh PC, Wein A, Vaughan ED, Retnik AB, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders Co; 1998:953-1000.
3. Kaplan SA, Chancellor MB, Blaivas JG. Bladder and sphincter behavior in patients with spinal cord lesions. J Urol. 1991;146:113-115.
4. Crowe R, Burnstock G, Light JK. Adrenergic innervation of the striated muscle of the intrinsic external urethral sphincter from patients with lower motor spinal cord lesion. J Urol. 1989;141:47-49.
5. Krane R, Olsson C. Phenoxybenzamine in neurogenic bladder dysfunction: I. A theory of micturition. J Urol. 1973;110:650-652.
6. Wyndaele JJ. Urology in male spinal cord injured patients. Paraplegia. 1987;25:267-269.
7. Killorin W, Gray M, Bennet JK, Green BG. The value of urodynamics and bladder management in predicting upper urinary tract complications in male spinal cord injury patients. Paraplegia. 1992;30:437-441.
8. Gerridzen RG, Thijssen AM, Dehoux E. Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol. 1992;147:416-418.
9. Chancellor MB, Erhard MJ, Rivas DA. Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function. J Am Paraplegia Soc. 1993;16:207-214.
10. Sundin T, Dahlstrom A. The sympathetic innervation of the urinary bladder and urethra in the normal state and after parasympathetic denervation at the spinal root level. Scand J Urol Nephrol. 1973;7:131-149.
11. Norlen L, Dahlstrom A, Sundin T, Svedmyr N. The adrenergic innervation and adrenergic receptor activity of the feline urinary bladder and urethra in the normal state and after hypogastric and/or parasympathetic denervation. Scand J Urol Nephrol. 1976;10:177-184.
12. Scott MB, Morrow JW. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury: I. voiding dysfunction. J Urol. 1978;119:480-482.
13. Scott MB, Morrow JW. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury: II. autonomic dysreflexia. J Urol. 1978;19:483-484.
14. Swierzewski III SJ, Gormley EA, Belville WD, Sweetser PM, Wan J, McGuire EJ. The effect of terazosin on bladder function in the spinal cord injured patient. J Urol. 1994;151:951-954.
15. Perkash I. Efficacy and safety of terazosin to improve voiding in spinal cord injury patients. J Spinal Cord Med. 1995;18:236-239.
16. McGuire EJ, Woodside J, Borden T, Weiss RM. The prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126:205-208.
17. Kim YH, Katten MW, Boone TB. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia. J Urol. 1998;159:493-497.
18. Wyndaele JJ. Urology in male spinal cord injured patients. Paraplegia. 1987;25:267-269.
19. Killorin W, Gray M, Bennet JK, Green BG. The value of urodynamics and bladder management in predicting upper urinary tract complications in male spinal cord injury patients. Paraplegia. 1992;30:437-441.
20. Gerridzen RG, Thijssen AM, Dehoux E. Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol. 1992;147:416-418.
21. Linsenmeyer TA, Bagaria SP, Gendron B. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med. 1998;21:15-20.